PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Rheumatology, Leiden University Medical Center, Leiden, The Netherlands fpbkroon@gmail.com.\', \'Rheumatology, Zuyderland Medical Center, Heerlen, The Netherlands.\', \'Institute of Infection, Immunity and Inflammation, University of Glasgow College of Medical Veterinary and Life Sciences, Glasgow, UK.\', \'Internal Medicine and Nephrology Unit, Department of Life, Health and Environmental Sciences, University of L\'Aquila, L\'Aquila, Italy.\', \'Directorate of Research Policy (formerly Walaeus Library), Leiden University Medical Center, Leiden, The Netherlands.\', \'Rheumatology & Clinical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands.\', \'Department of Rheumatology, London North West University Healthcare NHS Trust, London, UK.\', \'Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK.\', \'National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC), University College London Hospitals (UCLH) NHS Foundation Trust, London, UK.\', \'Rheumatology, University Hospital La Paz, Madrid, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/annrheumdis-2021-221575
?:doi
?:hasPublicationType
?:journal
  • Annals of the rheumatic diseases
is ?:pmid of
?:pmid
?:pmid
  • 34876462
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.699
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all